Cost Analysis of a Novel Enzymatic Debriding Agent for Management of Burn Wounds.

Biomed Res Int · 2017 · PMC5331316 · PMID 28293640

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

However, there is an increasing trend to treat larger burn areas with a single NXB application, with appropriate patient monitoring, as of now, with successful results and an unchanged safety profile.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.